WO2004029284A3 - Efficient generation of stable expression cell lines through the use of scorable homeostatic reporter genes - Google Patents

Efficient generation of stable expression cell lines through the use of scorable homeostatic reporter genes Download PDF

Info

Publication number
WO2004029284A3
WO2004029284A3 PCT/US2003/031311 US0331311W WO2004029284A3 WO 2004029284 A3 WO2004029284 A3 WO 2004029284A3 US 0331311 W US0331311 W US 0331311W WO 2004029284 A3 WO2004029284 A3 WO 2004029284A3
Authority
WO
WIPO (PCT)
Prior art keywords
cell
vector
scorable
homeostatic
methods
Prior art date
Application number
PCT/US2003/031311
Other languages
French (fr)
Other versions
WO2004029284A2 (en
Inventor
Robert B Dubridge
Original Assignee
Protein Design Labs Inc
Robert B Dubridge
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protein Design Labs Inc, Robert B Dubridge filed Critical Protein Design Labs Inc
Priority to AU2003283995A priority Critical patent/AU2003283995A1/en
Publication of WO2004029284A2 publication Critical patent/WO2004029284A2/en
Publication of WO2004029284A3 publication Critical patent/WO2004029284A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention provides methods for site-specific recombination in a cell, as well as vectors which can be employed in such methods. The methods and vectors of the present invention can be used to obtain persistent gene expression in a cell and to modulate gene expression. One preferred method according to the invention comprises contacting a cell with a vector comprising an origin of replication functional in mammalian cells located between first and second recombining sites located in parallel. Another preferred method comprises, in part, contacting a cell with a vector comprising first and second recombining sites in antiparallel orientations such that the vector is internalized by the cell. In both methods, the cell is further provided with a site-specific recombinase that effects recombination between the first and second recombining sites of the vector.
PCT/US2003/031311 2002-09-30 2003-09-30 Efficient generation of stable expression cell lines through the use of scorable homeostatic reporter genes WO2004029284A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003283995A AU2003283995A1 (en) 2002-09-30 2003-09-30 Efficient generation of stable expression cell lines through the use of scorable homeostatic reporter genes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41521602P 2002-09-30 2002-09-30
US60/415,216 2002-09-30

Publications (2)

Publication Number Publication Date
WO2004029284A2 WO2004029284A2 (en) 2004-04-08
WO2004029284A3 true WO2004029284A3 (en) 2005-05-12

Family

ID=32043428

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/031311 WO2004029284A2 (en) 2002-09-30 2003-09-30 Efficient generation of stable expression cell lines through the use of scorable homeostatic reporter genes

Country Status (3)

Country Link
US (2) US20040115814A1 (en)
AU (1) AU2003283995A1 (en)
WO (1) WO2004029284A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101555658B1 (en) 2007-05-25 2015-09-24 심포젠 에이/에스 Method for manufacturing a recombinant polyclonal protein

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1583830T1 (en) 2003-01-07 2006-12-31 Symphogen As Method for manufacturing recombinant polyclonal proteins
RS20060266A (en) * 2003-10-14 2008-09-29 Biogen Idec Ma Inc., Flp-mediated recombination
JP2011517317A (en) * 2008-02-28 2011-06-02 ライフ テクノロジーズ コーポレーション Fluorescence polarization hERG assay
EP2105505A1 (en) 2008-03-28 2009-09-30 Celonic AG Methods and materials for the reproducible generation of high producer cell lines for recombinant proteins
US10412788B2 (en) 2008-06-13 2019-09-10 Lg Chem, Ltd. Heating element and manufacturing method thereof
GB0810924D0 (en) * 2008-06-14 2008-07-23 Rowett Res Inst In vivo transgenics
US20130071881A1 (en) * 2009-11-19 2013-03-21 Immuno Tec Laboratory Co. Ltd Methods for producing antibody-producing cells that produce desired polypeptides
US20130244907A1 (en) * 2010-11-18 2013-09-19 National University Corporation Okayama University Method for preparing b cell which produces human-type antibody
AU2013318147B2 (en) 2012-09-19 2018-01-04 Abbvie Biotherapeutics Inc. Methods for identifying antibodies with reduced immunogenicity
US9910038B2 (en) 2012-11-30 2018-03-06 Larix Bioscience, Llc Cell line screening method
SG10201601929YA (en) * 2013-03-15 2016-04-28 Promega Corp Activation Of Bioluminescence By Structural Complementation
JP6788573B6 (en) 2014-04-10 2020-12-16 シアトル チルドレンズ ホスピタル， ディービーエー シアトル チルドレンズ リサーチ インスティテュート Production of genetically modified T cells by Sleeping Beauty transposon in combination with selection by methotrexate
GB201411344D0 (en) * 2014-06-26 2014-08-13 Univ Leicester Cloning
AU2016306209B2 (en) 2015-08-07 2023-07-06 Seattle Children's Hospital (dba Seattle Children's Research Institute) Bispecific CAR T-cells for solid tumor targeting
GB201703418D0 (en) 2017-03-03 2017-04-19 Ge Healthcare Bio Sciences Ab Method for cell line development
GB201703417D0 (en) 2017-03-03 2017-04-19 Ge Healthcare Bio Sciences Ab Method for cell line development

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US6091001A (en) * 1995-03-29 2000-07-18 Abgenix, Inc. Production of antibodies using Cre-mediated site-specific recombination
US6143557A (en) * 1995-06-07 2000-11-07 Life Technologies, Inc. Recombination cloning using engineered recombination sites
US20020007051A1 (en) * 1999-12-10 2002-01-17 David Cheo Use of multiple recombination sites with unique specificity in recombinational cloning

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202238A (en) * 1987-10-27 1993-04-13 Oncogen Production of chimeric antibodies by homologous recombination
WO1992015694A1 (en) * 1991-03-08 1992-09-17 The Salk Institute For Biological Studies Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor
BR0112633A (en) * 2000-07-21 2003-09-16 Us Agriculture Method for replacing, translocating and stacking DNA in eukaryotic genomes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US6091001A (en) * 1995-03-29 2000-07-18 Abgenix, Inc. Production of antibodies using Cre-mediated site-specific recombination
US6143557A (en) * 1995-06-07 2000-11-07 Life Technologies, Inc. Recombination cloning using engineered recombination sites
US20020007051A1 (en) * 1999-12-10 2002-01-17 David Cheo Use of multiple recombination sites with unique specificity in recombinational cloning

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101555658B1 (en) 2007-05-25 2015-09-24 심포젠 에이/에스 Method for manufacturing a recombinant polyclonal protein

Also Published As

Publication number Publication date
US20040115814A1 (en) 2004-06-17
WO2004029284A2 (en) 2004-04-08
US20060286671A1 (en) 2006-12-21
AU2003283995A1 (en) 2004-04-19
AU2003283995A8 (en) 2004-04-19

Similar Documents

Publication Publication Date Title
WO2004029284A3 (en) Efficient generation of stable expression cell lines through the use of scorable homeostatic reporter genes
NO980838L (en) Methods and vectors for site-specific recombination
Wang et al. Nonflammable trimethyl phosphate solvent-containing electrolytes for lithium-ion batteries: II. The use of an amorphous carbon anode
Staats et al. A statistical analysis of the effect of electric vehicle battery charging on distribution system harmonic voltages
Ratnakumar et al. Effects of SEI on the kinetics of lithium intercalation
Dance The binding and reduction of dinitrogen at an Fe4 face of the FeMo cluster of nitrogenase
CA2435013A1 (en) Fuel cell system with stored hydrogen
WO2003012913A3 (en) Method and product for improving performance of batteries/fuel cells
NO20013461L (en) Method for performing electrochemical reactions
Yang et al. Sinusoidal current and stress evolutions in lithium-ion batteries
Cheng et al. Effect of Pt nano-particle size on the microstructure of PEM fuel cell catalyst layers: Insights from molecular dynamics simulations
Vanags et al. Electrolyses model development for metal/electrolyte interface: Testing with microrespiration sensors
González Vayá et al. Locational marginal pricing based impact assessment of plug-in hybrid electric vehicles on transmission networks
Jefferies The origin and early fossil history of the acustico-lateralis system, with remarks on the reality of the echinoderm-hemichordate clade
Lin et al. Electrochemical and mechanical failure of graphite-based anode materials in Li-ion batteries for electric vehicles
CN107121537A (en) A kind of portable soil detection means
Lee et al. Performance and thermal stability of LiCoO2 cathode modified with ionic liquid
Thayer Radar measurements of the electromagnetic energy rates associated with the dynamic ionospheric load/generator
Ji et al. Static var compensator based on the method of synchronous symmetrical component.
Jin et al. Electrochemical and spectroelectrochemical studies on aniline in organic medium and its antiknock mechanism
Thiis et al. A TCO Analysis of the Transition to Battery Electric Trucks in Norway
CN206432340U (en) A kind of novel lithium-ion power battery block structure
Dai et al. Design of Fuel Cell/Lithium Battery Hybrid Energy Management Experiment Platform
Choube et al. Voltage collapse prediction based on line voltage stability index
Klar et al. Calculation of ionization with an error estimate

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP